Investigation of Mortality, Morbidity and Risk Factors After Pediatric Liver Transplantation
- Conditions
- Liver TransplantationLiver DiseasesMortalityMorbidity;InfantBiliary Atresia
- Interventions
- Procedure: Liver Transplantation
- Registration Number
- NCT04778735
- Lead Sponsor
- Memorial Bahçelievler Hospital
- Brief Summary
The Department of Organ Transplantation in Memorial Hospitals has started Pediatric Liver Transplantation Program in 2016. As of the end of 2020, we have performed 169 pediatric liver transplantation. The aim of this study is to investigate the overall mortality, morbidity and risk factors for adverse outcomes in pediatric liver transplantation. The patients' records will be retrospectively scanned and the data will be gathered.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 207
- Pediatric patients with liver transplantation (<18 years)
- Patients with incomplete medical records will be excluded
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Pediatric Patients with Liver Transplantation Liver Transplantation -
- Primary Outcome Measures
Name Time Method Survival 1 minutes Patient and graft survival ratios
- Secondary Outcome Measures
Name Time Method Perioperative informations 5 minutes Perioperative informations such as blood loss and blood transfusion
Postoperative Complications 5 minutes Postoperative Complications such as sepsis or hepatic artery thrombosis
Postoperative informations 10 minutes Postoperative informations such as initial hospital stay, ICU stay or mechanic ventilation time
Blood Tests 15 minutes Blood markers that evaluated at the pre and post operative phase such as Internation Normalized Ratio (INR), total bilirubin and albumin values.
Trial Locations
- Locations (1)
Memorial Bahçelievler Hospital
🇹🇷Istanbul, Turkey